Mumbai, May 8 -- Revenue from operations rose by 2.26% year-on-year (YoY) to Rs 4,517 crore during the period under review.

EBIDTA fell by 3.77% to Rs 1,073 crore while EBIDTA margin declined by 200 basis points YoY to 23% in Q4 FY26.

Profit before tax in Q4 FY26 stood at Rs 248 crore, down by 49.2% from Rs 487 crore in Q4 FY25.

For FY26, the company has recorded consolidated net profit and revenue from operations of Rs 386 crore (down 61.9% YoY) and Rs 16,927 crore (up 10.9% YoY), respectively.

Kiran Mazumdar-Shaw, executive chairperson, Biocon, said: "Biocon closed FY26 on a strong note despite a complex geopolitical environment.

We delivered margin expansion along with 13% YoY growth in operating revenue, excluding the one-time im...